Nofi Michael — SEC Form 4 filings
SEC reporting owner CIK 1705477. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2025-01-07 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) | Chief Accounting Officer | 3 | — | — | 11 |
| Edgewise Therapeutics, Inc. (EWTX) | Chief Financial Officer | 3 | — | — | 5 |
Form 4 filings — Nofi Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4/A | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 48,750 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 24,375 (derivative) @ $0 · Grant/award (A): 48,750 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 43,750 (derivative) @ $0 · Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Disposition to issuer (D): 30,623 · Disposition to issuer (D): 8,661 (derivative) · Disposition to issuer (D): 78,300 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,246 (derivative) | EDGAR |
| 2025-01-14 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 6,929 @ $0 · Grant/award (A): 20,246 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Tax withholding (F): 2,388 @ $38.19 · Tax withholding (F): 1,636 @ $38.19 · Tax withholding (F): 1,009 @ $38.86 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1705477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →